We are live on ! Find out more
HLA

Hamilton Lane Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 14.17%
This Fund
S&P 500
This Quarter Est. Return
-6.76%
1 Year Est. Return
-14.17%
3 Year Est. Return
+186.76%
5 Year Est. Return
+98.42%
10 Year Est. Return
+778.69%
AUM
$307M
AUM Growth
+$38.7M
Cap. Flow
+$59.6M
Cap. Flow %
19.41%
Top 10 Hldgs %
63.32%
Holding
82
New
33
Increased
4
Reduced
23
Closed
16

Top Buys

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$25.1M
2
PDD icon
Pinduoduo
PDD
+$24.1M
3
TENB icon
Tenable Holdings
TENB
+$20.2M
4
U icon
Unity
U
+$17.8M
5
DASH icon
DoorDash
DASH
+$16.3M

Top Sells

Rank Stock Value
1
ZM icon
Zoom
ZM
+$29.1M
2
NET icon
Cloudflare
NET
+$22.8M
3
CMRC
Commerce.com Inc Series 1
CMRC
+$12.6M
4
TXG icon
10x Genomics
TXG
+$9.43M
5
MDB icon
MongoDB
MDB
+$5.5M

Sector Composition

Rank Sector Weight
1 Technology 41.02%
2 Financials 22.4%
3 Healthcare 13.95%
4 Consumer Discretionary 12.91%
5 Communication Services 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
51
Natera
NTRA
$37.9B
$726K 0.24%
7,145
-21,266
-75% -$2.33M
BABA icon
52
Alibaba
BABA
$289B
$688K 0.22%
3,033
– –
SUMO
53
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$654K 0.21%
+34,658
New +$1.01M
ESPR
54
DELISTED
Esperion Therapeutics
ESPR
$596K 0.19%
21,253
-24,928
-54% -$735K
PLTR icon
55
Palantir
PLTR
$288B
$540K 0.18%
+23,167
New +$635K
PACB icon
56
Pacific Biosciences
PACB
$438M
$469K 0.15%
+14,091
New +$493K
DRNA
57
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$447K 0.15%
17,462
-12,443
-42% -$318K
OLMA icon
58
Olema Pharmaceuticals
OLMA
$1.02B
$402K 0.13%
+12,114
New +$519K
AR icon
59
Antero Resources
AR
$11B
$357K 0.12%
+35,046
New +$297K
ACEL icon
60
Accel Entertainment
ACEL
$968M
$355K 0.12%
32,493
– –
RPTX
61
DELISTED
Repare Therapeutics
RPTX
$337K 0.11%
+10,986
New +$373K
SONO icon
62
Sonos
SONO
$1.75B
$246K 0.08%
6,566
-76,227
-92% -$2.57M
OYST
63
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$211K 0.07%
+11,521
New +$242K
PMVP icon
64
PMV Pharmaceuticals
PMVP
$59.2M
$202K 0.07%
+6,154
New +$243K
RPT
65
Rithm Property Trust
RPT
$98.5M
$134K 0.04%
+2,048
New +$136K
ADVM
66
DELISTED
Adverum Biotechnologies
ADVM
– –
-5,462
Closed -$592K
ANAB icon
67
AnaptysBio
ANAB
$1.57B
– –
-41,017
Closed -$882K
APPS icon
68
Digital Turbine
APPS
$971M
– –
-26,846
Closed -$1.52M
BDTX icon
69
Black Diamond Therapeutics
BDTX
$94.5M
– –
-14,644
Closed -$469K
BNR
70
Burning Rock Biotech
BNR
$95.5M
– –
-4,442
Closed -$1.03M
DOYU
71
DouYu International Holdings
DOYU
$139M
– –
-12,730
Closed -$1.41M
ETNB
72
DELISTED
89bio
ETNB
– –
-24,285
Closed -$592K
FVRR icon
73
Fiverr
FVRR
$328M
– –
-6,805
Closed -$1.33M
GO icon
74
Grocery Outlet
GO
$898M
– –
-35,443
Closed -$1.39M
IDYA icon
75
IDEAYA Biosciences
IDYA
$3.46B
– –
-45,692
Closed -$640K
1 2
3
4

Similar funds

FFS
Flavin Financial Services Melbourne, Florida $149M AUM 14.79% 1-Year Est. Return
KCM
KM Capital Management Austin, Texas $149M AUM 18.7% 1-Year Est. Return
GCA
Gallagher Capital Advisors Argyle, Texas $148M AUM 20.92% 1-Year Est. Return
DAC
Dutch Asset Corp Selkirk, New York $149M AUM
RCM
Rockbridge Capital Management Alexandria, Virginia $149M AUM 1.06% 1-Year Est. Return
AWA
Authentikos Wealth Advisory Morgan Hill, California $148M AUM 9.86% 1-Year Est. Return
JWM
Jacksonville Wealth Management Jacksonville, Florida $148M AUM 23.77% 1-Year Est. Return
AWF
Alpha Wealth Funds Park City, Utah $149M AUM 10.03% 1-Year Est. Return

Hamilton Lane Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Hamilton Lane Advisors held 82 positions worth $307M, up 14% from $268M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Hamilton Lane Advisors deployed $59.6M of net new capital in Q1 2021, opening 33 new positions and adding to 4 existing holdings. Its largest new stake was Snowflake: 94,066 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 58% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Zoom, an estimated $29.1M trimmed.

  • Hamilton Lane Advisors's largest Q1 2021 buy was Snowflake: 94,066 shares worth $21.6M.
  • Hamilton Lane Advisors added most to Inari Medical, Inc. Common Stock in Q1 2021, an estimated $2.02M increase.
  • Hamilton Lane Advisors's biggest Q1 2021 reduction was Zoom, cutting an estimated $29.1M.
  • Hamilton Lane Advisors fully exited Digital Turbine in Q1 2021, selling an estimated $1.52M.
  • Hamilton Lane Advisors's ten largest holdings make up 63% of its $307M portfolio in Q1 2021.
  • Hamilton Lane Advisors opened 33 new positions and closed 16 in Q1 2021.
  • Hamilton Lane Advisors's portfolio value rose 14% quarter-over-quarter to $307M.

Based on Hamilton Lane Advisors's 13F filing for Q1 2021, filed 13 Apr 2021.